Development of a population pharmacokinetic model for Genasense™ and its active metabolites.

被引：0
|
作者：
Gupta, M
Julian, TN
Barrett, JS
机构：
[1] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA
[2] Genta Inc, Berkeley Hts, NJ USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2006年 / 79卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2005.12.194
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P54 / P54
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETIC AND MATHEMATICAL OUTLIERS FOR DRUGS WITH ACTIVE METABOLITES. NOTE I. MODEL INDEPENDENT ANALYSES FOR PENTOXIFYLLINE
    Mircioiu, Constantin
    Ionica, Georgeta
    Danilceac, Ala
    Miron, Dalia
    Mircioiu, Ionut
    Radulescu, Flavian
    [J]. FARMACIA, 2010, 58 (03) : 264 - 278
  • [2] BIOLOGICALLY ACTIVE SECONDARY METABOLITES.
    Ritchie, Graham
    [J]. Chemistry and Industry (London), 1985, (12): : 403 - 407
  • [3] A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents
    Kayode Ogungbenro
    Jonathan B. Wagner
    Susan Abdel-Rahman
    J. Steven Leeder
    Aleksandra Galetin
    [J]. European Journal of Clinical Pharmacology, 2019, 75 : 1227 - 1235
  • [4] A population pharmacokinetic model for simvastatin and its metabolites in children and adolescents
    Ogungbenro, Kayode
    Wagner, Jonathan B.
    Abdel-Rahman, Susan
    Leeder, J. Steven
    Galetin, Aleksandra
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (09) : 1227 - 1235
  • [5] Population pharmacokinetic modeling of molibresib and its active metabolites in patients with solid tumors: A semimechanistic autoinduction model
    Krishnatry, Anu Shilpa
    Voelkner, Alexander
    Dhar, Arindam
    Prohn, Marita
    Ferron-Brady, Geraldine
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (07): : 709 - 722
  • [6] Cyclophosphamide enhances the immunosuppressive action of its own active metabolites.
    Telegin L.Y.
    Pisarev V.M.
    Pevnitsky L.A.
    [J]. Doklady Biological Sciences, 2008, 423 (1) : 437 - 439
  • [7] Surfactant Degradation and Its Metabolites.
    Schoeberl, P.
    Bock, K.J.
    [J]. Tenside Detergents, 1980, 17 (05): : 262 - 266
  • [8] A mechanistic population pharmacokinetic model of abemaciclib and its metabolites and the impact of diarrhea
    Chigutsa, Emmanuel
    Kambhampati, Siva Rama Prasad
    Sykes, Amanda Karen
    Posada, Maria M.
    Turner, P. Kellie
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S30 - S30
  • [9] Population pharmacokinetic modeling of efavirenz and its metabolites
    Robarge, Jason D.
    Metzger, Ingrid F.
    Lu, Jessica
    Thong, Nancy
    Skaar, Todd C.
    Desta, Zeruesenay
    Bies, Robert R.
    [J]. DRUG METABOLISM REVIEWS, 2016, 48 : 135 - +
  • [10] A semiphysiological population pharmacokinetic model of agomelatine and its metabolites in Chinese healthy volunteers
    Xie, Feifan
    Vermeulen, An
    Colin, Pieter
    Cheng, Zeneng
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (05) : 1003 - 1014
12345